Epidemiological evidence indicates that there are irregular steady-state biological pathways in patients with depression, such as increased inflammation and disturbance of energy-regulated neuroendocrine signals (such as leptin and insulin) [42]. The gene discussed is LEP; the disease is depressive symptom measurement.